CAS 175481-37-5

(2S)-2-(Acetilamino)-3-metoxi-N-(fenilmetil)propanamida

Fórmula: C₁₃H₁₈N₂O₃

InChI: InChI=1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m0/s1

Clave InChI: InChIKey=VPPJLAIAVCUEMN-LBPRGKRZSA-N

SMILES: C(NC([C@@H](NC(C)=O)COC)=O)C1=CC=CC=C1

Sinónimos:

• (S)-2-Acetamido-N-benzyl-3-methoxypropanamide
• (2S)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide
• Propanamide, 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (S)-
• SPM 6953
• Propanamide, 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (2S)-

LACOSAMIDE IMPURITY A CRS

CAS: 175481-37-5

LACOSAMIDE IMPURITY A CRS

Ref: 41-Y0001972

Lacosamide S-Enantiomer

CAS: 175481-37-5

Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereof, nesoi

Fórmula: C₁₃H₁₈N₂O₃

Forma y color: White Powder

Peso molecular: 250.13174

Ref: 45-1357158

Epi-Lacosamide

CAS: 175481-37-5

Pureza: 97%

Ref: IN-DA00AKUQ

Lacosamide EP Impurity A ((S)-Lacosamide)

CAS: 175481-37-5

Fórmula: C₁₃H₁₈N₂O₃

Forma y color: White To Off-White Solid

Peso molecular: 250.30

Ref: 4Z-L-2812

(2S)-2-(Acetamido)-N-benzyl-3-methoxypropanamide

CAS: 175481-37-5

Forma y color: Neat

Ref: 86-MM3640.01

Epi-Lacosamide

CAS: 175481-37-5

Applications Epi-Lacosamide is an impurity of Lacosamide (L098500), a medication used for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. Lacosamide is a potent anticonvulsant.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Choi, D., et al.: J. Med. Chem., 39, 1907 (1996), Morieux, P., et al.: Bioorg. Med. Chem., 16, 8968 (2008),

Fórmula: C₁₃H₁₈N₂O₃

Forma y color: Neat

Peso molecular: 250.29

Ref: TR-E588795

Lacosamide EP Impurity A

CAS: 175481-37-5

Fórmula: C₁₃H₁₈N₂O₃

Peso molecular: 250.30

Ref: ST-EA-CP-L8001

(S)-2-Acetamido-N-benzyl-3-methoxypropanamide

Producto controlado

CAS: 175481-37-5

Lacosamide is a drug that is used to treat epilepsy and other neurological disorders. It acts as an inhibitor of voltage-gated sodium channels, which are proteins that regulate the passage of sodium ions through the cell membrane. Lacosamide has been shown to be effective in a number of clinical trials for stroke, Parkinson's disease, and Alzheimer's disease. This drug also has potential use in treating women with depression, based on its ability to inhibit serotonin reuptake and increase serotonin transmission. Lacosamide has been shown to be safe and well tolerated in clinical trials involving humans. There are no reports of serious side effects or deaths related to this drug.

Fórmula: C₁₃H₁₈N₂O₃

Pureza: Min. 95%

Peso molecular: 250.29 g/mol

Ref: 3D-FA151449